Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Anderson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Psychoactive Drugs|April 16, 2023
Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common PsychedelicsKelan L Thomas, Robert Jesse, Nicky J Mehtani, et al.
Current Topics in Behavioral Neurosciences|December 27, 2021
The Potential of Psychedelics for End of Life and Palliative CareDavid B Yaden, Sandeep M Nayak, Natalie Gukasyan, et al.
The American Journal of Psychiatry|January 1, 2025
Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy OptionsMaha N Mian, Michael T Dinh, Allison R Coker, et al.
Journal of Psychoactive Drugs|April 6, 2019
Psychedelic-Assisted Group Therapy: A Systematic ReviewAlexander Trope, Brian T Anderson, Andrew R Hooker, et al.
Journal of the American College of Emergency Physicians Open|September 10, 2025
US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022Juan Carlos C Montoy, Ralph C Wang, Allison R Coker, et al.
Current Topics in Behavioral Neurosciences|November 22, 2025
Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory ResearchMaha N Mian, Allison R Coker, Grace Kretzer, et al.
Journal of Psychoactive Drugs|August 5, 2025
Latent Classes of Lifetime Use of Seven Hallucinogens in the United StatesMeredith C Meacham, Maha N Mian, Ralph C Wang, et al.
Journal of Psychopharmacology (Oxford, England)|January 19, 2024
Older adults in psychedelic-assisted therapy trials: A systematic reviewLisa Bouchet, Zachary Sager, Antoine Yrondi, et al.
Journal of Psychoactive Drugs|November 10, 2025
Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use DisordersNicky J Mehtani, Maha N Mian, Gabrielle Agin-Liebes, et al.
BMJ Open|August 24, 2025
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risksNicky J Mehtani, Brian T Anderson, Irina Alexander, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Psychoactive Drugs|April 16, 2023
Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common PsychedelicsKelan L Thomas, Robert Jesse, Nicky J Mehtani, et al.
Current Topics in Behavioral Neurosciences|December 27, 2021
The Potential of Psychedelics for End of Life and Palliative CareDavid B Yaden, Sandeep M Nayak, Natalie Gukasyan, et al.
The American Journal of Psychiatry|January 1, 2025
Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy OptionsMaha N Mian, Michael T Dinh, Allison R Coker, et al.
Journal of Psychoactive Drugs|April 6, 2019
Psychedelic-Assisted Group Therapy: A Systematic ReviewAlexander Trope, Brian T Anderson, Andrew R Hooker, et al.
Journal of the American College of Emergency Physicians Open|September 10, 2025
US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022Juan Carlos C Montoy, Ralph C Wang, Allison R Coker, et al.
Current Topics in Behavioral Neurosciences|November 22, 2025
Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory ResearchMaha N Mian, Allison R Coker, Grace Kretzer, et al.
Journal of Psychoactive Drugs|August 5, 2025
Latent Classes of Lifetime Use of Seven Hallucinogens in the United StatesMeredith C Meacham, Maha N Mian, Ralph C Wang, et al.
Journal of Psychopharmacology (Oxford, England)|January 19, 2024
Older adults in psychedelic-assisted therapy trials: A systematic reviewLisa Bouchet, Zachary Sager, Antoine Yrondi, et al.
Journal of Psychoactive Drugs|November 10, 2025
Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use DisordersNicky J Mehtani, Maha N Mian, Gabrielle Agin-Liebes, et al.
BMJ Open|August 24, 2025
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risksNicky J Mehtani, Brian T Anderson, Irina Alexander, et al.
Pageof 3